CHICAGO, IL, Opternative, an eye healthcare technology company, announced today it has secured $9M in its latest round of funding.
The round of financing was led by Trust Ventures and Pritzker Group Venture Capital, with an additional investment from existing investor Jump Capital.
Opternative will use the funding to double its engineering, product, sales and marketing teams. The funding will also be used to grow awareness and adoption of its online vision test with consumers, employers and eye care providers.
"With this latest round of funding, Opternative is now poised to significantly grow its position as a pioneer in the eye healthcare technology space," said Salen Churi, Founder and General Partner of Trust Ventures. "This investment solidifies Opternative as one of Chicago's most promising and innovative companies."
"Opternative is at the forefront of eye healthcare technology by expanding its national and global reach of their leading digital vision test," said Peter Liu, Vice President of Pritzker Group Venture Capital. "I am thrilled to be on the board of such a cutting-edge company and look forward to working closing with Opternative on their long-term growth plans."
"This is only the beginning of great things to come for Opternative," said Brent Rasmussen, Chief Executive Officer of Opternative. "We've had great success in partnering with eyewear retailers and eye care providers, and this meaningful investment is a great affirmation of the tremendous traction we've achieved and will enable us to aggressively focus on continued international growth and furthering our partnerships with everyone in the industry."
(c) by Massinvestor, Inc. For contact info, please check out our
about page.